Analysen zu Novo Nordisk
| 20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.24 | Novo Nordisk Halten | DZ BANK | |
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 27.01.26 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | PUMA Hold | Jefferies & Company Inc. | |
| 27.01.26 | AB InBev Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 27.01.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | Ryanair Outperform | RBC Capital Markets | |
| 27.01.26 | FRIEDRICH VORWERK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | Nokia Overweight | JP Morgan Chase & Co. | |
| 27.01.26 | Ryanair Overweight | JP Morgan Chase & Co. | |
| 27.01.26 | Continental Overweight | JP Morgan Chase & Co. | |
| 27.01.26 | K+S Underperform | Jefferies & Company Inc. | |
| 27.01.26 | BASF Underweight | JP Morgan Chase & Co. | |
| 27.01.26 | Fielmann Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.26 | ING Group Hold | Jefferies & Company Inc. | |
| 26.01.26 | Volvo AB Buy | Jefferies & Company Inc. | |
| 26.01.26 | GEA Sector Perform | RBC Capital Markets | |
| 26.01.26 | GEA Underweight | JP Morgan Chase & Co. | |
| 26.01.26 | GEA Buy | Jefferies & Company Inc. | |
| 26.01.26 | Knorr-Bremse Halten | DZ BANK | |
| 26.01.26 | Intel Verkaufen | DZ BANK | |
| 26.01.26 | Drägerwerk vz. Halten | DZ BANK | |
| 26.01.26 | Raiffeisen neutral | Deutsche Bank AG | |
| 26.01.26 | Wienerberger Sell | UBS AG | |
| 26.01.26 | Meta Platforms Outperform | RBC Capital Markets | |
| 26.01.26 | Amazon Outperform | RBC Capital Markets | |
| 26.01.26 | Alphabet A Outperform | RBC Capital Markets | |
| 26.01.26 | Stabilus Overweight | JP Morgan Chase & Co. | |
| 26.01.26 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 26.01.26 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 26.01.26 | Apple Hold | Jefferies & Company Inc. | |
| 26.01.26 | Delivery Hero Buy | Jefferies & Company Inc. | |
| 26.01.26 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 26.01.26 | TotalEnergies Buy | Jefferies & Company Inc. | |
| 26.01.26 | Siemens Energy Buy | Jefferies & Company Inc. | |
| 26.01.26 | Siemens Buy | Jefferies & Company Inc. | |
| 26.01.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 26.01.26 | Intesa Sanpaolo Buy | UBS AG | |
| 26.01.26 | Commerzbank Neutral | Goldman Sachs Group Inc. | |
| 26.01.26 | Apple Overweight | JP Morgan Chase & Co. | |
| 26.01.26 | Mercedes-Benz Group Buy | Goldman Sachs Group Inc. | |
| 26.01.26 | Ryanair Buy | UBS AG | |
| 26.01.26 | Infineon Buy | UBS AG | |
| 26.01.26 | STMicroelectronics Buy | UBS AG | |
| 26.01.26 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 26.01.26 | Hermès Neutral | UBS AG | |
| 26.01.26 | Richemont Buy | UBS AG | |
| 26.01.26 | VINCI Buy | UBS AG | |
| 26.01.26 | Münchener Rückversicherungs-Gesellschaft Neutral | UBS AG | |
| 26.01.26 | Danone Overweight | JP Morgan Chase & Co. | |
| 26.01.26 | Swiss Re Neutral | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.